Starting Atomoxetine at 40 mg Daily
No, you should not start atomoxetine at 40 mg daily in most patients—the FDA-approved initial dose for children/adolescents over 70 kg and adults is 40 mg, but only after understanding the patient's weight and metabolic status. For patients under 70 kg, starting at 40 mg would exceed recommended dosing and increase the risk of early adverse events, particularly nausea and somnolence.
Weight-Based Dosing Algorithm
For children and adolescents ≤70 kg:
- Start at 0.5 mg/kg/day for minimum 3 days
- Then increase to target of 1.2 mg/kg/day 1
- For a 50 kg patient, this means starting at 25 mg, not 40 mg
- Maximum dose: 1.4 mg/kg or 100 mg (whichever is less)
For children/adolescents >70 kg and adults:
- Start at 40 mg/day for minimum 3 days
- Then increase to target of 80 mg/day 1
- After 2-4 additional weeks, may increase to maximum 100 mg if response inadequate
Why Slower Titration Matters
The evidence strongly supports gradual dose escalation to minimize adverse events. Research comparing fast versus slow titration strategies found that rapid titration to therapeutic doses significantly increased early adverse events 2:
- Fast titration (3 days): 14.3% decreased appetite, 14.3% somnolence
- Slow titration (≥2 weeks): 8.0% decreased appetite, 4.2% somnolence
The FDA label explicitly warns that "initial somnolence and gastrointestinal tract symptoms, particularly if the dosage is increased too rapidly" are common adverse effects 3. Starting at 40 mg in a patient who should receive 25 mg essentially bypasses this protective titration period.
Special Populations Requiring Lower Starting Doses
Reduce initial dose to 0.5 mg/kg/day (or 40 mg in adults) if:
- Taking strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) 1
- Known CYP2D6 poor metabolizers
- Only increase to usual target after 4 weeks if symptoms don't improve AND initial dose is well tolerated
Hepatic impairment:
- Moderate (Child-Pugh B): Reduce to 50% of normal dose
- Severe (Child-Pugh C): Reduce to 25% of normal dose 1
Clinical Rationale
The 40 mg starting dose exists specifically for patients >70 kg because it approximates 0.5 mg/kg in a 70-80 kg individual. Using 40 mg in lighter patients delivers a higher mg/kg dose than intended, increasing adverse event risk without improving efficacy. Studies show no additional benefit for doses higher than 1.2 mg/kg/day 1.
Common Pitfall to Avoid
Don't assume "40 mg is the standard starting dose" because you see it on the label—this applies only to heavier patients. Always calculate weight-based dosing for patients under 70 kg. The most common early adverse events (nausea, decreased appetite, somnolence) are dose-dependent and can lead to early discontinuation if titration is too aggressive 3, 2, 4.
Bottom line: Weigh your patient first. Under 70 kg = start at 0.5 mg/kg (often 25 mg for typical pediatric patients). Over 70 kg = 40 mg is appropriate. Wait minimum 3 days before any dose increase.